Gary Mather

1.5k total citations
36 papers, 1.3k citations indexed

About

Gary Mather is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Gary Mather has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Gary Mather's work include Pharmacogenetics and Drug Metabolism (5 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Gary Mather is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Gary Mather collaborates with scholars based in United States, France and Belgium. Gary Mather's co-authors include René H. Levy, Alan Pidcock, W. Trager, David A. Erickson, James J. Keirns, Jerry H. Exon, Jeanine L. Bussiere, Loren D. Koller, William Trager and Ben Tseng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Gary Mather

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Mather United States 19 354 270 250 240 217 36 1.3k
Barbra H. Stewart United States 20 172 0.5× 514 1.9× 317 1.3× 128 0.5× 439 2.0× 38 1.6k
Geert Mannens Belgium 25 149 0.4× 472 1.7× 289 1.2× 353 1.5× 550 2.5× 59 2.1k
Frank S. Abbott Canada 25 115 0.3× 227 0.8× 940 3.8× 480 2.0× 471 2.2× 65 1.7k
David D. Christ United States 25 401 1.1× 335 1.2× 86 0.3× 25 0.1× 537 2.5× 49 1.9k
David J. Rance United Kingdom 15 95 0.3× 452 1.7× 157 0.6× 78 0.3× 636 2.9× 18 1.7k
Jan‐Olof Svensson Sweden 22 35 0.1× 162 0.6× 221 0.9× 210 0.9× 239 1.1× 40 1.5k
Cheryl L. Zimmerman United States 20 78 0.2× 177 0.7× 89 0.4× 52 0.2× 581 2.7× 63 1.4k
Lindsey O. Webster United States 11 75 0.2× 1.0k 3.9× 555 2.2× 95 0.4× 398 1.8× 14 1.7k
Kimberly K. Adkison United States 21 65 0.2× 606 2.2× 291 1.2× 74 0.3× 368 1.7× 42 1.7k
Matthew D. Troutman United States 21 159 0.4× 1.1k 4.0× 527 2.1× 98 0.4× 880 4.1× 30 2.4k

Countries citing papers authored by Gary Mather

Since Specialization
Citations

This map shows the geographic impact of Gary Mather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Mather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Mather more than expected).

Fields of papers citing papers by Gary Mather

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Mather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Mather. The network helps show where Gary Mather may publish in the future.

Co-authorship network of co-authors of Gary Mather

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Mather. A scholar is included among the top collaborators of Gary Mather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Mather. Gary Mather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baichwal, Vijay, J. Adam Willardsen, Jeffrey W. Lockman, et al.. (2011). Activity of the cancer metabolism inhibitor MPC-9528 in xenograft models: Comparison of different dosing schedules.. Journal of Clinical Oncology. 29(15_suppl). 10529–10529. 1 indexed citations
2.
Samlowski, Wolfram E., K. Papadopoulos, Anthony J. Olszanski, et al.. (2011). Abstract A96: Phase 1 study of HSP90 inhibitor MPC-3100 in subjects with refractory or recurrent cancer.. Molecular Cancer Therapeutics. 10(11_Supplement). A96–A96. 7 indexed citations
3.
Sirisoma, Nilantha, Azra Pervin, Hong Zhang, et al.. (2010). Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure–activity relationship of the quinazoline ring. Bioorganic & Medicinal Chemistry Letters. 20(7). 2330–2334. 44 indexed citations
4.
Galasko, Douglas, N. R. Graff-Radford, Susanne May, et al.. (2007). Safety, Tolerability, Pharmacokinetics, and Aβ Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals. Alzheimer Disease & Associated Disorders. 21(4). 292–299. 94 indexed citations
5.
Bradford, Chad, et al.. (2005). MPC-6827, a small molecule inhibitor of microtubule formation with high brain penetration: absorption, distribution, metabolism, excretion, and clinical considerations. Cancer Research. 65. 804–804. 5 indexed citations
6.
Ragueneau‐Majlessi, Isabelle, René H. Levy, Donna Bergen, et al.. (2004). Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Research. 62(1). 1–11. 28 indexed citations
7.
Sachdeo, Rǎjesh C., René H. Levy, Anthony J. Streeter, et al.. (2002). Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients. Epilepsia. 43(7). 691–696. 50 indexed citations
8.
9.
Erickson, David A., Gary Mather, W. Trager, René H. Levy, & James J. Keirns. (1999). Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450. Drug Metabolism and Disposition. 27(12). 1488–1495. 231 indexed citations
10.
Tran, Agnès, Elisabeth Rey, Gérard Pons, et al.. (1997). Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants*. Clinical Pharmacology & Therapeutics. 62(5). 490–504. 89 indexed citations
11.
Glue, Paul, Christopher Banfield, James L. Perhach, et al.. (1997). Pharmacokinetic Interactions with Felbamate. Clinical Pharmacokinetics. 33(3). 214–224. 44 indexed citations
12.
Morganroth, Joel, William H. Lyness, James L. Perhach, et al.. (1997). Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers. The Journal of Clinical Pharmacology. 37(11). 1065–1072. 12 indexed citations
13.
Bulgin, Marie S., et al.. (1996). Elemental sulfur toxicosis in a flock of sheep. Journal of the American Veterinary Medical Association. 208(7). 1063–1065. 28 indexed citations
14.
Mather, Gary, Patricia A. Talcott, & Jerry H. Exon. (1994). Characterization of a Chemically Induced Tumor Model and the Effects of Natural Killer Cell Depletion by Antiasialo GM-1. Immunobiology. 190(4-5). 333–345. 15 indexed citations
15.
Bussiere, Jeanine L., Jerry H. Exon, & Gary Mather. (1991). Effects of Bromocriptine Treatment on Immune Responses and 3–Methylcholanthrene-Induced Tumorigenesis in Rats. Immunopharmacology and Immunotoxicology. 13(1-2). 47–64. 3 indexed citations
16.
Bussiere, Jeanine L., Gary Mather, & Jerry H. Exon. (1991). Effect of Cyclosporine on 3-Methylcholanthrene-Induced Carcinogenesis and Immune Responses in the Rat. Immunobiology. 182(3-4). 205–215. 7 indexed citations
17.
Talcott, Patricia A., Jerry H. Exon, Gary Mather, & Loren D. Koller. (1990). Alterations of rat natural killer (NK) cell cytotoxicity and cytokine production by 3-methylcholanthrene (3-MC). International Journal of Immunopharmacology. 12(8). 917–926. 9 indexed citations
18.
Mather, Gary, Jerry H. Exon, & Loren D. Koller. (1990). Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acid in rats. Toxicology. 64(1). 71–80. 50 indexed citations
19.
Mather, Gary, et al.. (1973). Correlation of nuclear magnetic resonance coupling constants with transition metal–ligand bond lengths in tertiary phosphine complexes. Journal of the Chemical Society Dalton Transactions. 2095–2099. 72 indexed citations
20.
Mather, Gary, et al.. (1973). Effect of anionic ligands on 31P-N.M.R. parameters trialkylphosphine complexes of platinum(II). Inorganic and Nuclear Chemistry Letters. 9(5). 567–570. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbra H. Stewart Breakdown of academic impact, for papers by Geert Mannens Breakdown of academic impact, for papers by Frank S. Abbott Breakdown of academic impact, for papers by David D. Christ Breakdown of academic impact, for papers by David J. Rance Breakdown of academic impact, for papers by Jan‐Olof Svensson Breakdown of academic impact, for papers by Cheryl L. Zimmerman Breakdown of academic impact, for papers by Lindsey O. Webster Breakdown of academic impact, for papers by Kimberly K. Adkison Breakdown of academic impact, for papers by Matthew D. Troutman
Rankless by CCL
2026